Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 164

Results For "TERI"

1819 News Found

Lancet Respiratory Medicine publishes Phase 2 data of Medigen Covid-19 vaccine
News | October 16, 2021

Lancet Respiratory Medicine publishes Phase 2 data of Medigen Covid-19 vaccine

The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres


Govt. removes export curbs on Covid-19 kits
Policy | October 16, 2021

Govt. removes export curbs on Covid-19 kits

The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification


Dr Reddy’s Lab launches carmustine in the US market
Drug Approval | October 16, 2021

Dr Reddy’s Lab launches carmustine in the US market

The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health


Govt launches `One Health’ surveillance programme
Public Health | October 15, 2021

Govt launches `One Health’ surveillance programme

The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens


Exelixis in-licenses second anti-cancer compound from Aurigene
Biotech | October 15, 2021

Exelixis in-licenses second anti-cancer compound from Aurigene

U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma


Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
Biotech | October 14, 2021

Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis

Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations


Lonza to expand development services for mammalian products in Singapore
Biotech | October 13, 2021

Lonza to expand development services for mammalian products in Singapore

This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites


Tarsons earmarks funds from IPO to double capacity at its Panchla facility
News | October 12, 2021

Tarsons earmarks funds from IPO to double capacity at its Panchla facility

An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion


LSNE expands lyophilization capacity at Madison, USA
Biotech | October 12, 2021

LSNE expands lyophilization capacity at Madison, USA

This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site


Covaxin for kids gets nod, final approval awaited
Drug Approval | October 12, 2021

Covaxin for kids gets nod, final approval awaited

The two doses of Covaxin are likely to be administered to children with a gap of 28 days